发明名称 |
SUBSTITUTION INFUSION FLUID AND CITRATE ANTICOAGULATION |
摘要 |
<p>The invention relates to a substitution infusion fluid for hemofiltration of a specific composition. The use of said substitution infusion fluid significantly reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration. The invention also relates to process for pure hemofiltration of blood wherein said substitution infusion fluid is used. The invention also relates to a matching citrate anticoagulation fluid of a specific composition. The invention also relates to a process for pure hemofiltration of blood wherein said substitution infusion fluid is used in combination with said citrate anticoagulation fluid. The use of said substitution infusion fluid in combination with said citrate anticoagulation fluid significantly further reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration.</p> |
申请公布号 |
EP1176969(B1) |
申请公布日期 |
2008.08.20 |
申请号 |
EP20000927004 |
申请日期 |
2000.04.20 |
申请人 |
EDWARDS LIFESCIENCES AG |
发明人 |
CHANG, PE CHOU |
分类号 |
A61K33/42;A61K31/70;A61K33/06;A61K33/14;A61K38/18;A61M1/34;A61M1/36;A61P7/08 |
主分类号 |
A61K33/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|